Hojjat Ahmadzadehfar

5PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersPharmaceutical delivery technologiesRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 20, 2023
Potential Role of Somatostatin Receptor Scintigraphy for In Vivo Imaging of Vulnerable Atherosclerotic Plaques and Its Association with Myocardial Perfusion Imaging Finding: A Preliminary Study.

Abdullatif Amini, Esmail Jafari, Mohammad Reza Pourbehi

|Jun 04, 2021
Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in a Case of Concurrent Neuroendocrine Tumors and Meningioma: Achieving Two Things in a Single Action

Majid Assadi, Seyed Javad Rekabpour, Abdullatif Amini

|May 25, 2021
The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [177Lu]Lu-PSMA-617: a WARMTH multicentre study.

Hojjat Ahmadzadehfar, Ralf Matern, Richard P Baum

|Sep 22, 2020
Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [223Ra]RaCl2 therapy.

Miriam Sraieb, Nader Hirmas, Rupert Conrad

|Jul 25, 2019
Quality of life in patients with midgut NET following peptide receptor radionuclide therapy.

Milka Marinova, Martin Mücke, Felix Fischer

Pageof 1

Frequent Collaborators

2 joint publications

Reza Nemati

2 joint publications

Esmail Jafari

1 joint publications

Nader Hirmas

1 joint publications

Milka Marinova